- TheStreet.com•6 days ago
Progenics, Alexion and BioCryst were among the biotech stock movers in premarket trading on Thursday.
- PR Newswire•7 days ago
NEW YORK, Feb. 15, 2017 /PRNewswire/ -- Effective with this press release, S&P Dow Jones Indices will now reference index changes using an "effective at the open" date rather than an "after ...
- GlobeNewswire•8 days agoProgenics Pharmaceuticals Announces Initiation of a Phase 1 Clinical Trial of its PSMA-Targeted Therapeutic Candidate 1095 For the Treatment of Metastatic Prostate Cancer
NEW YORK, Feb. 14, 2017-- Progenics Pharmaceuticals, Inc., an oncology company developing innovative medicines and other products for targeting and treating cancer, today announced that enrollment of an ...
PGNX : Summary for Progenics Pharmaceuticals Inc. - Yahoo Finance
Progenics Pharmaceuticals, Inc. (PGNX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||10.27 x 1100|
|Ask||10.28 x 300|
|Day's Range||10.21 - 10.49|
|52 Week Range||3.80 - 10.84|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||66.32|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|